DE602006018308D1 - Chimärer impfstoff für haemophilus influenzae-induzierte infektion - Google Patents

Chimärer impfstoff für haemophilus influenzae-induzierte infektion

Info

Publication number
DE602006018308D1
DE602006018308D1 DE602006018308T DE602006018308T DE602006018308D1 DE 602006018308 D1 DE602006018308 D1 DE 602006018308D1 DE 602006018308 T DE602006018308 T DE 602006018308T DE 602006018308 T DE602006018308 T DE 602006018308T DE 602006018308 D1 DE602006018308 D1 DE 602006018308D1
Authority
DE
Germany
Prior art keywords
haemophilus influenzae
protein
chimeric vaccine
induced infection
nthi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006018308T
Other languages
English (en)
Inventor
Lauren O Bakaletz
Robert S Munson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nationwide Childrens Hospital Inc
Original Assignee
Nationwide Childrens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nationwide Childrens Hospital Inc filed Critical Nationwide Childrens Hospital Inc
Publication of DE602006018308D1 publication Critical patent/DE602006018308D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE602006018308T 2005-07-08 2006-07-05 Chimärer impfstoff für haemophilus influenzae-induzierte infektion Active DE602006018308D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69764205P 2005-07-08 2005-07-08
US80183506P 2006-05-19 2006-05-19
PCT/US2006/026183 WO2007008527A2 (en) 2005-07-08 2006-07-05 Chimeric vaccine for haemophilus influenzae-induced disease

Publications (1)

Publication Number Publication Date
DE602006018308D1 true DE602006018308D1 (de) 2010-12-30

Family

ID=37441871

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006018308T Active DE602006018308D1 (de) 2005-07-08 2006-07-05 Chimärer impfstoff für haemophilus influenzae-induzierte infektion

Country Status (7)

Country Link
US (3) US7811591B2 (de)
EP (2) EP1904519B1 (de)
JP (2) JP2009500037A (de)
AT (1) ATE488526T1 (de)
CA (1) CA2613970C (de)
DE (1) DE602006018308D1 (de)
WO (1) WO2007008527A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
US7811591B2 (en) * 2005-07-08 2010-10-12 Nationwide Children's Hospital, Inc. Chimeric vaccine for haemophilus influenzae-induced disease
TW201302779A (zh) * 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗
CN104968366B (zh) * 2012-10-17 2017-12-01 葛兰素史密丝克莱恩生物有限公司 包含一种或多种肺炎链球菌荚膜糖缀合物和含有来自流感嗜血杆菌的蛋白E和/或PilA的蛋白组分的免疫原性组合物
GB201218660D0 (en) 2012-10-17 2012-11-28 Glaxosmithkline Biolog Sa Immunogenic composition
AU2014225330B2 (en) 2013-03-08 2018-11-01 Lauren O. Bakaletz Transcutaneous dosage formulation
US11274144B2 (en) 2013-06-13 2022-03-15 Research Institute At Nationwide Children's Hospital Compositions and methods for the removal of biofilms
US11248040B2 (en) 2013-09-26 2022-02-15 Trellis Bioscience, Llc Binding moieties for biofilm remediation
US20180207067A1 (en) 2015-07-14 2018-07-26 Research Institute at Nationwide Children's Hospit al Novel formulation for the elimination of cariogenic and opportunistic pathogens within the oral cavity
JP2018528763A (ja) 2015-07-31 2018-10-04 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル バイオフィルムの除去のためのペプチドおよび抗体
EP3365027B1 (de) 2015-10-14 2022-03-30 Research Institute at Nationwide Children's Hospital Hu-spezifische antikörper und deren verwendeng zur hemmung von biofilm
CA3049105A1 (en) 2017-01-04 2018-07-12 Lauren O. Bakaletz Dnabii vaccines and antibodies with enhanced activity
CN112851812B (zh) * 2020-06-30 2021-09-14 广州百暨基因科技有限公司 抗b7h3抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US19005A (en) 1857-12-29 de witt
US697642A (en) 1901-03-09 1902-04-15 Liberty Millet Process of strengthening clay hydraulic pipe, vases, crockery-ware, &c.
US801835A (en) 1905-02-25 1905-10-17 Rudolph H Apelt Ball-bearing.
US1900504A (en) 1930-11-25 1933-03-07 Ingersoll Rand Co Condensing apparatus
DE69431624T2 (de) * 1993-05-18 2003-07-10 Univ Ohio State Res Found Impfstoff gegen mittelohrentzündung
DE4336530C1 (de) * 1993-10-26 1995-04-13 Max Planck Gesellschaft Rekombinante PilC-Proteine, Verfahren zu ihrer Herstellung und ihre Verwendung
US6355450B1 (en) * 1995-04-21 2002-03-12 Human Genome Sciences, Inc. Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
US5843464A (en) * 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
PT2192127E (pt) * 2003-12-23 2012-08-06 Nationwide Children S Hospital Inc Pili de tipo iv de haemophilus influenzae
US7811591B2 (en) * 2005-07-08 2010-10-12 Nationwide Children's Hospital, Inc. Chimeric vaccine for haemophilus influenzae-induced disease

Also Published As

Publication number Publication date
US20130064828A1 (en) 2013-03-14
EP2298794A2 (de) 2011-03-23
EP1904519A2 (de) 2008-04-02
JP2010172332A (ja) 2010-08-12
US8741304B2 (en) 2014-06-03
WO2007008527A2 (en) 2007-01-18
EP1904519B1 (de) 2010-11-17
EP2298794A3 (de) 2011-04-06
ATE488526T1 (de) 2010-12-15
US20080311110A1 (en) 2008-12-18
WO2007008527A3 (en) 2007-03-15
CA2613970C (en) 2015-12-08
US8263363B2 (en) 2012-09-11
US20110081357A1 (en) 2011-04-07
US7811591B2 (en) 2010-10-12
JP2009500037A (ja) 2009-01-08
CA2613970A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
ATE488526T1 (de) Chimärer impfstoff für haemophilus influenzae- induzierte infektion
CO6491045A2 (es) Composiciones de proteina f de virus sincitial respiratorio (rsv) y metodos para producir las mismas
AR086078A1 (es) Proteinas de fusion y vacunas de combinacion
HK1221232A1 (zh) 種包含 未端、及含有李斯特菌素 蛋白質片段融合到 抗原的 序列的疫苗
WO2004030608A3 (en) Nanoemulsion vaccines
DK1929047T3 (da) Fremgangsmåder og sammensætninger til vaccination af dyr med PRRSV-antigener med forbedret immunogenicitet
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
DE122011100053I1 (de) Influenza vakzinzusammensetzungen zur intradermaler verabreichung.
SG169375A1 (en) Yeast-based vaccine for inducing an immune response
EA200701305A1 (ru) Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида
ATE461710T1 (de) Nipah-virus-impfstoffe
MXPA05009580A (es) Vacuna contra el virus de la influenza.
ATE557041T1 (de) Peptid-vakzinen gegen streptokokken der gruppe a
MA30581B1 (fr) Vaccin viral recombinant
WO2008002663A3 (en) Immunogenic protein constructs
WO2007016185A3 (en) Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination
NO20081043L (no) Vaksine for fisk
ME01140B (me) Virus goveđe virusne dijareje s modifikovanim erns proteinom
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
MX2009007572A (es) Proteinas de fusion que contienen los antigenos de rechazo de tumor ny-eso-1 y.
NZ760789A (en) Uti fusion proteins
MX2020006601A (es) Composicion inmunogenica.
ATE370745T1 (de) Verbesserte polysaccharid- und glykokonjugat- vakzine
WO2006007366A3 (en) SKIN IMMUNIZATION USING LT-STa FUSION PROTEINS
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof